Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cystoid macular edema (CME) is one of the common causes of vision loss in patients with UveitiS .Triamcinolone has been effectively used in reducing CME and improving the vision. Also there are some documents which recommend Bevacizumab(avastin) could reduce macular edema. This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.
This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Active Comparator | Intravitreal injection of Triamcinolone |
|
| 2 | Active Comparator | Intravitreal injection of Avastin |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intravitreal injection of Triamcinolone | Drug | 4 mg of Triamcinolone |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Resorbed CME in OCT | every 3 month | |
| Resorbed CME in clinical examination | Every 3 month |
| Measure | Description | Time Frame |
|---|---|---|
| need to retreatment | when ever needed |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Masoud Soheilian, MD | Ophthalmic Research Center of Shaheed Beheshti Medical University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Masoud Soheilian , MD | Tehran | Tehran Province | 16666 | Iran |
Not provided
Not provided
Not provided
Not provided
Not provided
| Intravitreal injection of Avastin |
| Drug |
Injection of 1.25 mg of Avastin and |
|